Skip to main content
OpenTrials
Enrolling by invitation

NCT Number: NCT06469814

Snapshot Study on Patients With Heart Failure

The goal of this observational study is to provide a better understanding of medical practice for heart failure management based on real-world data, collected both across Europe and the rest of the world, using robust methodology and representativeness within each country.

Standard management of patients will be the diagnostic and therapeutic interventions routinely performed in each center for patients presenting with signs and symptoms of chronic/acute heart failure.

Enrolling by invitation

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Astghik Medical Center, Yerevan, Armenia

Loading trial locations.

About this study

Information collected by the GRASP-HF study assesses adherence to the ESC HF Guidelines focusing on Quality Indicators, in both chronic and acute HF.

For that reason, the GRASP-HF snapshot study is evolving in parallel with the long-term Heart Failure Association initiative - ICARe-HF: the Improving Care through Accreditation and Recognition in Heart Failure (ICARe-HF) programme. ICARe-HF is an international accreditation programme for heart failure centres which is about improving patient outcomes by raising standards in care facilities and recognising those that apply best practices. The GRASP-HF snapshot study serves to verify the performance of individual centres through data collection of real-world patient data.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult patients with chronic or acute Heart Failure (HF), regardless of ejection fraction, either:

  • Outpatient with chronic HF (including first-time diagnosis), according to the clinical judgment.

OR

  • Patients admitted to hospital or presenting to Emergency Department or Acute out-patient care for acute HF for whom an IV (diuretics, inotropes, vasodilators) or mechanical therapy for HF (mechanical circulatory support) is administered.

Exclusion criteria

  • Age <18 years
  • Patients unwilling to consent (or patient's legally authorized representative unwilling to consent, if the patient is unable to consent).

Treatment and study plan

Primary outcomes

  1. Adherence to ESC Guidelines in Heart Failure 2021

    Time frame: 12 months per site

    Full adherence to guidelines for heart failure management

Sponsors and collaborators

Lead sponsor

European Society of Cardiology

Network

Registry information

Official study title

Global Registries And Surveys Programme - Heart Failure Snapshot Study (GRASP-HF)

Acronym: GRASP-HF

Important dates

Study start
2024
Primary completion
2025
Study completion
2029
First posted
Jun 24, 2024
Registry last updated
Aug 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.